Gene Transfer Technologies Market by Product (Instruments, Kits, Assays), Mode (Viral (Retrovirus, Adenovirus, AAV), Non-viral (Electroporation, Gene Gun)), Method (In-Vivo, In-vitro), Application, (Gene Therapy, Research) - Global Forecast to 2029

icon1
USD 5.93 BN
MARKET SIZE, 2029
icon2
CAGR 9.7%
(2024-2029)
icon3
525
REPORT PAGES
icon4
774
MARKET TABLES

OVERVIEW

Gene Transfer Technologies Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The gene delivery technology market is projected to reach USD 5.93 billion by 2029 from USD 3.73 billion in 2024, at a CAGR of 9.7% from 2024 to 2029. Gene delivery is a process in which genetic material, such as DNA or RNA, is transferred to target cells using viral and non-viral vectors. Its market growth is fueled by the growing demand for personalized medicine and cell and gene therapies, as well as increased investments in gene therapy research to enhance gene transfer technology revenues.

KEY TAKEAWAYS

  • The Asia Pacific is expected to grow the fastest, with a CAGR of 10.7% during the forecast period, fueled by rapid industrialization and strong research and development activities in countries like China, Japan, and India.
  • Based on the product, reagents, kits, and assays segment accounted for the largest share of 40.1% the gene delivery technologies market in 2023.
  • On the basis of mode segmentation, the viral vectors segment is projected to grow at the fastest rate of 10.5% from 2024 to 2029.
  • By method, the in vivo gene delivery method segment is expected to dominate the market.
  • Among application segments, therapeutic applications is anticipated to grow at a highest CAGR during the forecast period.
  • By end user, pharmaceutical and biotechnology companies hold the largest share among end users, followed by academic and research institutes.
  • Thermo Fisher Scientific, Danaher Corporation, Merck, QIAGEN and Sartorius AG were identified as some of the star players in the gene delivery technology market (global), given their strong market share and product footprint.
  • VectorBuilder, RJH BioSciences, and Flash Therapeutics have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders

The gene delivery technology market is projected to grow rapidly over the next decade, supported by increasing demand for personalized medicines and cell and gene therapies, as well as increased investments in gene therapy research. Industries are increasingly turning to gene transfer technology for its unmatched ability to enable precise, efficient, and durable delivery of genetic material into target cells. Growing emphasis on personalized medicine, rare disease treatment, and curative approaches further strengthens its role as a breakthrough platform, setting the foundation for broad adoption across biopharmaceutical research, clinical applications, and industrial biotechnology.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The impact on the gene delivery technology market is shaped by evolving trends among patients, researchers, and healthcare providers. The market has witnessed key shifts that are expected to intensify over the forecast period. These include the rising prevalence of genetic and rare diseases, increasing adoption of personalized and precision medicine, growing demand for advanced viral and non-viral delivery systems, and heightened focus on gene therapy applications across oncology, immunology, and regenerative medicine. Such short- and long-term trends are projected to reshape research, clinical trials, and therapeutic development, thereby creating significant growth opportunities for gene delivery technology providers, biotech companies, and supporting suppliers..

Gene Transfer Technologies Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Growing demand for personalized medicines and cell and gene therapies
  • Increased investments in gene therapy research
RESTRAINTS
Impact
Level
  • High cost of gene delivery systems
  • Difficulty associated with mass production
OPPORTUNITIES
Impact
Level
  • Advancements in gene editing technologies and nanotechnology
  • Integration with digital technologies such as AI and ML
CHALLENGES
Impact
Level
  • Scalability of production

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Growing demand for personalized medicines and cell and gene therapies

The demand for personalized cell and gene therapies is rising due to their ability to target diseases at the genetic and cellular level, offering higher efficacy, reduced side effects, and durable treatment outcomes. These therapies enable tailored interventions for cancer, rare genetic disorders, and autoimmune diseases. Further, advancements in viral vectors, CRISPR-based editing, and cell manufacturing technologies are enhancing precision, safety, and scalability. These attributes make personalized cell and gene therapies highly attractive for oncology, the management of rare diseases, and regenerative medicine.

Restraint: Difficulty associated with mass production

The large-scale implementation of personalized cell and gene therapies faces significant challenges due to the high cost of gene delivery systems, complex manufacturing processes, and stringent regulatory requirements. Although technological advancements are gradually reducing expenses, the substantial upfront investment remains a barrier to widespread adoption. This limits the use of these therapies primarily to specialized, high-margin applications, such as rare genetic disorders and certain types of cancer. Overcoming these costs and production hurdles is crucial for broader accessibility and unlocking the full potential of personalized cell and gene therapies across healthcare.

Opportunity: Advancements in gene editing technologies and nanotechnology

Advancements in gene editing technologies and nanotechnologies offer precise targeting, enhanced delivery, and improved safety, making them highly suitable for next-generation therapies. Thus, the adoption of these technologies is expected to increase in applications such as personalized cell and gene therapies, targeted cancer treatments, regenerative medicine, and the management of rare diseases.

Challenge: Scalability of production

Scaling the production of personalized cell and gene therapies poses a significant challenge for critical applications, including oncology, rare diseases, and regenerative medicine. Complex manufacturing processes, batch-to-batch variability, and stringent quality requirements can limit consistency and efficacy. Further, the lack of standardized large-scale production protocols and integration with existing biomanufacturing infrastructure hinders widespread adoption. Overcoming these hurdles is crucial for the growth of personalized therapies and their broader accessibility in healthcare.

Gene Transfer Technologies Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Non-viral genetic medicine platform uses “immune-quiet DNA (iqDNA)” + cell-targeted LNPs (ctLNP) for delivering DNA cargo Reduced immune detection (cytokine profiles comparable to mRNA) in mice & non-human primates
Non-viral delivery of gene therapy (oncology + diabetes) with nanoparticle / LNP systems Important advantage over many viral vector approaches due to the ability to re-dose
GenEdit’s NanoGalaxy platform (polymer nanoparticles, non-viral, non-lipid) in partnership with Sarepta to develop gene editing therapeutics for neuromuscular diseases Allows payload flexibility, tissue selectivity, ability to re-dose
Developing lipid nanoparticle (LNP) technologies targeted at “extrahepatic delivery” (i.e. beyond the liver) for RNA therapeutics in rare and cardiometabolic diseases Improved potency & safety and therapeutic impact in rare & cardiometabolic diseases
Engineering of DNA nanoparticles; licensed a UC Berkeley technology for non-viral gene delivery (CRISPR-Cas + HDR arms) enabling “folding” of genes into their own delivery vehicles Increased efficiency of non-viral gene delivery, especially for large constructs

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The gene delivery technology ecosystem comprises interconnected relationships among various stakeholders, including raw material suppliers, technology developers, biopharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), distributors, and end-users. Raw material suppliers provide essential components such as plasmid DNA, mRNA, lipids, polymers, and viral vector backbones to technology developers. These developers and manufacturers utilize platforms such as lipid nanoparticles (LNPs), polymer-based carriers, electroporation, and viral vector engineering to create efficient delivery systems. CDMOs and specialized service providers scale up production, ensuring compliance with regulatory standards and quality control. Distributors and supply partners bridge the gap between manufacturers and end users, including pharmaceutical and biotechnological companies, academic research institutes, and clinical centers, thereby optimizing the supply chain. This integrated ecosystem enhances operational efficiency, accelerates therapeutic development, and drives the commercialization of gene therapies and RNA-based therapeutics.

Gene Transfer Technologies Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Gene Transfer Technologies Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Gene delivery technology Market, By Product

The reagents and kits segment held the largest share in the gene delivery market in 2024, driven by their essential role in facilitating precise and efficient genetic manipulation. While instruments and consumables support experimental and clinical workflows, reagents and kits provide ready-to-use components that streamline protocols, reduce variability, and accelerate research and therapeutic applications. Their widespread adoption is driven by the increasing development of gene therapy, mRNA-based treatments, and the need for standardized, scalable solutions across laboratories and clinics.

Gene delivery technology Market, By Mode

The viral vectors segment accounted for the largest share in the gene delivery market in 2024, owing to their high efficiency, stable gene expression, and ability to target specific cells and tissues. While non-viral methods offer safety and scalability advantages, viral vectors remain preferred for clinical and therapeutic applications. Growing adoption of viral platforms in gene therapies, mRNA treatments, and rare disease interventions has reinforced their dominant position in both research and commercial settings.

Gene delivery technology Market, By Method

The in vivo segment led the gene delivery market in 2024, driven by the direct administration of genetic material using carriers such as lipid nanoparticles, viral vectors, or polymers. Preferred for its high efficiency, precise targeting, and scalability, it surpasses labor-intensive ex vivo and research-focused in vitro methods. The successes of mRNA vaccines, emerging gene therapies, and advances in delivery platforms, including non-viral vectors, have reinforced in vivo delivery as the dominant clinical and commercial approach.

Gene delivery technology Market, By Application

The therapeutic applications segment dominated the gene delivery market in 2024, driven by the growing demand for gene and cell therapies targeting rare, genetic, and cardiometabolic diseases. While research and other applications support discovery and development, therapeutic use remains the primary revenue driver, driven by clinical translation, regulatory approvals, and commercial adoption. Advances in delivery platforms, vector design, and standardized protocols have further strengthened the prominence of therapeutic applications in the market.

Gene delivery technology Market, By End User

The pharmaceutical and biotechnology companies segment held the largest share in the gene delivery market in 2024, driven by their focus on developing gene and cell therapies, mRNA vaccines, and advanced biologics. While academic and research institutes, as well as other end users, support discovery and early-stage development, industry adoption remains the key revenue driver. Investments in scalable delivery platforms, high-throughput capabilities, and clinical translation have reinforced the dominance of pharmaceutical and biotech companies in the market.

REGION

Asia Pacific to be fastest-growing region in global gene delivery technology market during forecast period

The Asia Pacific gene delivery technology market is expected to register the highest CAGR during the forecast period, driven by increasing investments in gene therapy, mRNA vaccines, and biotechnology research. Key players in countries such as China, Japan, and South Korea are expanding their capabilities in viral and non-viral delivery platforms, reagents, and kits to support therapeutic and research applications. Growing healthcare infrastructure, rising demand for advanced therapies, and ongoing R&D initiatives are accelerating the adoption of gene delivery technologies across the region.

Gene Transfer Technologies Market Region

Gene Transfer Technologies Market: COMPANY EVALUATION MATRIX

Thermo Fisher Scientific, Inc. (Star) leads with a strong market presence and an extensive portfolio of viral and non-viral delivery platforms, reagents, and kits, driving widespread adoption in therapeutic and research applications. Revvity (Emerging Leader) is gaining traction with innovative gene delivery solutions and scalable platforms for mRNA and gene therapies. While companies like Merck dominate in manufacturing scale, smaller players such as VectorBuilder show strong growth potential to advance toward the leaders' quadrant.

Gene Transfer Technologies Market Evaluation Matrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2023 (Value) USD 3.63 Billion
Market Forecast in 2029 (Value) USD 5.93 Billion
Growth Rate CAGR of 9.7% from 2024-2029
Years Considered 2022-2029
Base Year 2023
Forecast Period 2024-2029
Units Considered Value (USD Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Product:
    • Instruments
    • Consumables
    • Reagents
    • Kits
    • Assays
  • By Mode: Viral Vector and Non-viral Vector
  • By Method:
    • Ex Vivo
    • In Vivo
    • In Vitro
  • By Application:
    • Research Applications
    • Therapeutic Applications
    • Other Applications
  • By End User:
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Other End Users
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

WHAT IS IN IT FOR YOU: Gene Transfer Technologies Market REPORT CONTENT GUIDE

Gene Transfer Technologies Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Supply Chain & Manufacturing Insights Analysis of CDMO capabilities, raw material sourcing, and bottlenecks in vector production Supports operational planning and risk mitigation in manufacturing and logistics
Environmental & Ethical Impact Assessment Evaluation of sustainability, biosafety, and ethical considerations in gene delivery technologies Enhances investor confidence, and regulatory compliance planning
Cross-Technology Comparison Comparative analysis of gene delivery vs. other therapeutic modalities (e.g., RNAi, cell therapy) in terms of efficacy, scalability, and cost Enables strategic decision-making on technology investments and portfolio diversification

RECENT DEVELOPMENTS

  • September 2024 : Cytiva launched the RNA delivery LNP kit designed for use with the NanoAssembl Ignite and Ignite+ systems, extending the GenVox-ILM product line to accelerate mRNA and siRNA vaccine development.
  • September 2024 : MaxCyte and Kamau Therapeutic entered into a strategic platform license (SPL) agreement under which Kamau obtained non-exclusive research, clinical, and commercial rights to utilize MaxCyte's Flow Electroporation technology and EXPERT platform to support its novel homology-directed repair (HDR) gene correction technology.
  • August 2024 : Merck acquired Mirus Bio to advance Merck's integrated offering for viral vector manufacturing.
  • March 2024 : Sartorius launched RPLUS, AAV-RC2, a Bercar plasmid for adeno-associated virus vector 2 (AAV2) production, further expanding the plasmid portfolio to address the range of AAV serotypes.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
48
2
RESEARCH METHODOLOGY
 
 
 
52
3
EXECUTIVE SUMMARY
 
 
 
64
4
PREMIUM INSIGHTS
 
 
 
69
5
MARKET OVERVIEW
Gene therapy market surges with personalized medicine demand and AI-driven technological advancements.
 
 
 
72
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
GROWING DEMAND FOR PERSONALIZED MEDICINE AND CELL & GENE THERAPIES
 
 
 
 
5.2.1.2
INCREASED INVESTMENTS IN GENE THERAPY RESEARCH
 
 
 
 
5.2.1.3
EXPANDING APPLICATIONS IN VACCINE DEVELOPMENT & CANCER IMMUNOTHERAPY
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
HIGH COSTS OF GENE DELIVERY SYSTEMS
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
ADVANCEMENTS IN GENE EDITING TECHNOLOGIES & NANOTECHNOLOGY
 
 
 
 
5.2.3.2
INTEGRATION WITH DIGITAL TECHNOLOGIES SUCH AS AI & ML
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
SCALABILITY OF PRODUCTION
 
 
5.3
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.3.1
PRODUCT PROVIDERS
 
 
 
 
5.3.2
END USERS
 
 
 
 
5.3.3
REGULATORY BODIES
 
 
 
5.4
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.4.1
KEY TECHNOLOGIES
 
 
 
 
 
5.4.1.1
MICROINJECTION
 
 
 
 
5.4.1.2
ELECTROPORATION
 
 
 
 
5.4.1.3
SONOPORATION
 
 
 
5.4.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.4.2.1
GENE EDITING TECHNOLOGIES
 
 
 
 
5.4.2.2
BIOINFORMATICS AND COMPUTATIONAL TOOLS
 
 
 
5.4.3
ADJCENT TECHNOLOGIES
 
 
 
 
 
5.4.3.1
NANOTECHNOLOGY AND NANO-CARRIERS
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND OF REAGENTS/CONSUMABLES, BY KEY PLAYER
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION
 
 
 
5.6
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.7
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.8
PATENT ANALYSIS
 
 
 
 
 
5.9
TRADE ANALYSIS
 
 
 
 
 
 
5.9.1
IMPORT DATA FOR MACHINES AND APPARATUS FOR ELECTROPLATING, ELECTROLYSIS OR ELECTROPHORESIS (HS CODE: 854330)
 
 
 
 
5.9.2
EXPORT DATA FOR MACHINES AND APPARATUS FOR ELECTROPLATING, ELECTROLYSIS OR ELECTROPHORESIS (HS CODE: 854330)
 
 
 
5.10
KEY CONFERENCES AND EVENTS, 2024–2025
 
 
 
 
5.11
REGULATORY LANDSCAPE
 
 
 
 
 
5.11.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
5.11.2
REGULATORY FRAMEWORK
 
 
 
 
 
5.11.2.1
NORTH AMERICA
 
 
 
 
5.11.2.2
EUROPE
 
 
 
 
5.11.2.3
ASIA PACIFIC
 
 
 
 
5.11.2.4
REST OF THE WORLD
 
 
5.12
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.12.1
THREAT OF NEW ENTRANTS
 
 
 
 
5.12.2
THREAT OF SUBSTITUTES
 
 
 
 
5.12.3
BARGAINING POWER OF BUYERS
 
 
 
 
5.12.4
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.12.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.13
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
5.13.1
KEY STAKEHOLDERS
 
 
 
 
5.13.2
BUYING CRITERIA
 
 
 
5.14
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.15
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
5.16
IMPACT OF AI/GEN AI ON GENE TRANSFER TECHNOLOGIES MARKET
 
 
 
 
6
GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 29 Data Tables
 
 
 
104
 
6.1
INTRODUCTION
 
 
 
 
6.2
REAGENTS, KITS, AND ASSAYS
 
 
 
 
 
6.2.1
INCREASING DEMAND FOR TRANSFECTION AND GENE EDITING TOOLS TO DRIVE MARKET GROWTH
 
 
 
6.3
CONSUMABLES
 
 
 
 
 
6.3.1
RISING R&D ACTIVITY TO SUPPORT DEMAND GROWTH
 
 
 
6.4
INSTRUMENTS
 
 
 
 
 
6.4.1
INCREASING ADOPTION OF ELECTROPORATION DEVICES TO DRIVE MARKET
 
 
 
6.5
OTHER PRODUCTS
 
 
 
7
GENE TRANSFER TECHNOLOGIES MARKET, BY MODE
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 139 Data Tables
 
 
 
119
 
7.1
INTRODUCTION
 
 
 
 
7.2
VIRAL VECTORS
 
 
 
 
 
7.2.1
RETROVIRUSES
 
 
 
 
 
7.2.1.1
LENTIVIRUSES
 
 
 
 
7.2.1.2
OTHER RETROVIRUSES
 
 
 
7.2.2
ADENOVIRUSES
 
 
 
 
 
7.2.2.1
EXPANSION OF VACCINATION PROGRAMS TO PROPEL MARKET GROWTH
 
 
 
7.2.3
ADENO-ASSOCIATED VIRUSES
 
 
 
 
 
7.2.3.1
LOW IMMUNOGENICITY OF AAV VECTORS TO SUPPORT ADOPTION
 
 
 
7.2.4
OTHER VIRAL VECTORS
 
 
 
7.3
NON-VIRAL VECTORS
 
 
 
 
 
7.3.1
CHEMICAL METHODS
 
 
 
 
7.3.2
LIPOSOME-MEDIATED
 
 
 
 
 
7.3.2.1
HIGH EFFICIENCY AND COMPATIBILITY TO DRIVE MARKET
 
 
 
7.3.3
CALCIUM PHOSPHATE
 
 
 
 
 
7.3.3.1
INCREASING R&D IN CELL-BASED THERAPIES TO PROPEL MARKET GROWTH
 
 
 
7.3.4
DEAE-DEXTRAN
 
 
 
 
 
7.3.4.1
SIMPLICITY AND COST-EFFECTIVENESS TO SUPPORT ADOPTION
 
 
 
7.3.5
CATIONIC POLYMERS
 
 
 
 
 
7.3.5.1
ADVANCEMENTS IN CATIONIC POLYMER TECHNOLOGY TO DRIVE MARKET
 
 
 
7.3.6
OTHER CHEMICAL METHODS
 
 
 
7.4
PHYSICAL METHODS
 
 
 
 
 
7.4.1
ELECTROPORATION
 
 
 
 
 
7.4.1.1
RISING DEMAND FOR EFFECTIVE CELL TRANSFECTION TECHNOLOGIES TO DRIVE MARKET
 
 
 
7.4.2
MICROINJECTION
 
 
 
 
 
7.4.2.1
HIGH ACCURACY AND CONTROL AND POTENTIAL FOR TAILORED DELIVERY TO DRIVE MARKET
 
 
 
7.4.3
GENE GUNS
 
 
 
 
 
7.4.3.1
HIGH EFFICIENCY OF GENE GUNS IN TRANSFECTING VARIOUS CELL TYPES TO DRIVE MARKET
 
 
 
7.4.4
OTHER PHYSICAL METHODS
 
 
8
GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 22 Data Tables
 
 
 
186
 
8.1
INTRODUCTION
 
 
 
 
8.2
IN VIVO
 
 
 
 
 
8.2.1
EMERGENCE OF MRNA-BASED VACCINES TO PROPEL IN VIVO GENE DELIVERY APPLICATIONS
 
 
 
8.3
EX VIVO
 
 
 
 
 
8.3.1
SUCCESSFUL COMMERCIALIZATION OF CAR T-CELL THERAPIES TO DRIVE THE EX VIVO GENE DELIVERY MARKET
 
 
 
8.4
IN VITRO
 
 
 
 
 
8.4.1
DATABASES MAJORLY CONTRIBUTE TO STORING GENE TRANSFER TECHNOLOGIES AND INTEGRATING OTHER OMICS DATABASES.
 
 
9
GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 102 Data Tables
 
 
 
198
 
9.1
INTRODUCTION
 
 
 
 
9.2
THERAPEUTIC APPLICATIONS
 
 
 
 
 
9.2.1
GENE THERAPY
 
 
 
 
 
9.2.1.1
INCREASING DEMAND FOR PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
 
 
 
9.2.2
CELL THERAPY
 
 
 
 
 
9.2.2.1
RISING GOVERNMENT FUNDING TO PROPEL MARKET GROWTH
 
 
 
9.2.3
VACCINES
 
 
 
 
 
9.2.3.1
RISING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH
 
 
 
9.2.4
OTHER THERAPEUTIC APPLICATIONS
 
 
 
9.3
RESEARCH APPLICATIONS
 
 
 
 
 
9.3.1
DRUG DISCOVERY & DEVELOPMENT
 
 
 
 
 
9.3.1.1
INCREASED FUNDING FOR GENE THERAPY RESEARCH TO DRIVE MARKET GROWTH
 
 
 
 
9.3.1.2
CANCER
 
 
 
9.3.2
INFECTIOUS DISEASES
 
 
 
 
 
9.3.2.1
RISING INCIDENCE OF INFECTIOUS DISEASE TO DRIVE MARKET GROWTH
 
 
 
9.3.3
GENETIC & NEUROLOGICAL DISORDERS
 
 
 
 
 
9.3.3.1
RISING BURDEN OF DISORDERS TO DRIVE MARKET
 
 
 
9.3.4
AUTOIMMUNE DISEASES
 
 
 
 
 
9.3.4.1
GROWING PREVALENCE OF AUTOIMMUNE DISORDERS TO ENSURE DEMAND FOR THERAPEUTIC SOLUTIONS
 
 
 
9.3.5
OTHER DISEASES
 
 
 
 
9.3.6
OTHER RESEARCH APPLICATIONS
 
 
 
9.4
OTHER APPLICATIONS
 
 
 
10
GENE TRANSFER TECHNOLOGIES MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2029 in USD Million | 22 Data Tables
 
 
 
249
 
10.1
INTRODUCTION
 
 
 
 
10.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
10.2.1
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT TO DOMINATE MARKET
 
 
 
10.3
ACADEMIC & RESEARCH INSTITUTES
 
 
 
 
 
10.3.1
INCREASING R&D AND GROWING FUNDING AND PARTNERSHIPS TO PROMOTE MARKET GROWTH
 
 
 
10.4
OTHER END USERS
 
 
 
11
GENE TRANSFER TECHNOLOGIES MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 16 Countries | 377 Data Tables.
 
 
 
261
 
11.1
INTRODUCTION
 
 
 
 
11.2
NORTH AMERICA
 
 
 
 
 
11.2.1
NORTH AMERICA: MACROECONOMIC OUTLOOK
 
 
 
 
11.2.2
US
 
 
 
 
 
11.2.2.1
US TO DOMINATE NORTH AMERICAN MARKET OVER FORECAST PERIOD
 
 
 
11.2.3
CANADA
 
 
 
 
 
11.2.3.1
STRONG INFRASTRUCTURE AND AVAILABILITY OF FUNDING FOR BIOMEDICAL RESEARCH TO SUPPORT MARKET GROWTH
 
 
11.3
EUROPE
 
 
 
 
 
11.3.1
EUROPE: MACROECONOMIC OUTLOOK
 
 
 
 
11.3.2
GERMANY
 
 
 
 
 
11.3.2.1
GERMANY TO HOLD LARGEST MARKET SHARE IN EUROPE
 
 
 
11.3.3
UK
 
 
 
 
 
11.3.3.1
INCREASING GOVERNMENT FUNDING TO DRIVE MARKET GROWTH
 
 
 
11.3.4
FRANCE
 
 
 
 
 
11.3.4.1
RISING SUPPORT FOR GENETIC RESEARCH TO OFFER POTENTIAL GROWTH OPPORTUNITIES
 
 
 
11.3.5
ITALY
 
 
 
 
 
11.3.5.1
RISING R&D AND SUPPORT FOR GENE DELIVERY TO DRIVE MARKET
 
 
 
11.3.6
SPAIN
 
 
 
 
 
11.3.6.1
GROWING EXPANSION OF RESEARCH CENTERS TO STIMULATE MARKET
 
 
 
11.3.7
REST OF EUROPE
 
 
 
11.4
ASIA PACIFIC
 
 
 
 
 
11.4.1
ASIA PACIFIC: MACROECONOMIC OUTLOOK
 
 
 
 
11.4.2
CHINA
 
 
 
 
 
11.4.2.1
INCREASING R&D EXPENDITURE TO DRIVE MARKET GROWTH
 
 
 
11.4.3
JAPAN
 
 
 
 
 
11.4.3.1
RISING RESEARCH INTO PRECISION MEDICINE TO SUPPORT MARKET GROWTH
 
 
 
11.4.4
INDIA
 
 
 
 
 
11.4.4.1
STRONG RESEARCH BASE AND RISING FDI IN PHARMA SECTOR TO SUPPORT MARKET GROWTH
 
 
 
11.4.5
SOUTH KOREA
 
 
 
 
 
11.4.5.1
ALLIANCES & INVESTMENTS IN RESEARCH TO DRIVE MARKET
 
 
 
11.4.6
AUSTRALIA
 
 
 
 
 
11.4.6.1
INCREASING FOCUS ON PRECISION MEDICINE TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES
 
 
 
11.4.7
REST OF ASIA PACIFIC
 
 
 
11.5
LATIN AMERICA
 
 
 
 
 
11.5.1
LATIN AMERICA: MACROECONOMIC OUTLOOK
 
 
 
 
11.5.2
BRAZIL
 
 
 
 
 
11.5.2.1
BRAZIL TO HOLD LARGEST MARKET SHARE IN LATAM
 
 
 
11.5.3
MEXICO
 
 
 
 
 
11.5.3.1
STRONG PHARMACEUTICAL INDUSTRY AND INCREASED GOVERNMENT SUPPORT TO AUGMENT MARKET GROWTH
 
 
 
11.5.4
REST OF LATIN AMERICA
 
 
 
11.6
MIDDLE EAST
 
 
 
 
 
11.6.1
MIDDLE EAST: MACROECONOMIC OUTLOOK
 
 
 
 
11.6.2
GCC COUNTRIES
 
 
 
 
 
11.6.2.1
SAUDI ARABIA
 
 
 
 
11.6.2.2
UAE
 
 
 
 
11.6.2.3
REST OF GCC COUNTRIES
 
 
 
11.6.3
REST OF MIDDLE EAST
 
 
 
11.7
AFRICA
 
 
 
 
 
11.7.1
RISING EMPHASIS ON GENE TRANSFER TECHNOLOGIES FOR THERAPEUTICS TO SUPPORT MARKET GROWTH
 
 
 
 
11.7.2
MACROECONOMIC OUTLOOK FOR AFRICA
 
 
12
COMPETITIVE LANDSCAPE
Discover strategic market shifts and emerging leaders in GENE TRANSFER TECHNOLOGIES.
 
 
 
415
 
12.1
OVERVIEW
 
 
 
 
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
12.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN GENE TRANSFER TECHNOLOGIES MARKET
 
 
 
12.3
REVENUE ANALYSIS
 
 
 
 
 
12.4
MARKET SHARE ANALYSIS
 
 
 
 
 
12.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
 
 
 
 
 
 
12.5.1
STARS
 
 
 
 
12.5.2
EMERGING LEADERS
 
 
 
 
12.5.3
PERVASIVE PLAYERS
 
 
 
 
12.5.4
PARTICIPANTS
 
 
 
 
12.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2023
 
 
 
 
 
12.5.5.1
COMPANY FOOTPRINT
 
 
 
 
12.5.5.2
REGION FOOTPRINT
 
 
 
 
12.5.5.3
PRODUCT FOOTPRINT
 
 
 
 
12.5.5.4
METHOD FOOTPRINT
 
 
 
 
12.5.5.5
APPLICATION FOOTPRINT
 
 
 
 
12.5.5.6
END-USER FOOTPRINT
 
 
12.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
 
 
 
 
 
 
12.6.1
PROGRESSIVE COMPANIES
 
 
 
 
12.6.2
RESPONSIVE COMPANIES
 
 
 
 
12.6.3
DYNAMIC COMPANIES
 
 
 
 
12.6.4
STARTING BLOCKS
 
 
 
 
12.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
 
 
 
12.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
12.7.1
FINANCIAL METRICS
 
 
 
 
12.7.2
COMPANY VALUATION
 
 
 
12.8
BRAND/PRODUCT COMPARISON
 
 
 
 
 
12.9
COMPETITIVE SCENARIO
 
 
 
 
 
12.9.1
PRODUCT LAUNCHES
 
 
 
 
12.9.2
DEALS
 
 
 
 
12.9.3
EXPANSIONS
 
 
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
433
 
13.1
KEY PLAYERS
 
 
 
 
 
13.1.1
THERMO FISHER SCIENTIFIC INC.
 
 
 
 
 
13.1.1.1
BUSINESS OVERVIEW
 
 
 
 
13.1.1.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
13.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
13.1.1.4
MNM VIEW
 
 
 
13.1.2
DANAHER CORPORATION
 
 
 
 
13.1.3
MERCK KGAA
 
 
 
 
13.1.4
BIO-RAD LABORATORIES, INC.
 
 
 
 
13.1.5
AGILENT TECHNOLOGIES, INC.
 
 
 
 
13.1.6
REVVITY
 
 
 
 
13.1.7
QIAGEN
 
 
 
 
13.1.8
GENSCRIPT
 
 
 
 
13.1.9
TAKARA BIO INC.
 
 
 
 
13.1.10
PROMEGA CORPORATION
 
 
 
 
13.1.11
BIO-TECHNE
 
 
 
 
13.1.12
LONZA
 
 
 
 
13.1.13
OXFORD BIOMEDICA PLC
 
 
 
 
13.1.14
SARTORIUS AG
 
 
 
 
13.1.15
MAXCYTE
 
 
 
13.2
OTHER PLAYERS
 
 
 
 
 
13.2.1
CELL BIOLABS, INC.
 
 
 
 
13.2.2
GENTARGET INC.
 
 
 
 
13.2.3
ORIGENE TECHNOLOGIES, INC.
 
 
 
 
13.2.4
ALTOGEN BIOSYSTEMS
 
 
 
 
13.2.5
OZ BIOSCIENCES
 
 
 
 
13.2.6
GENECOPOEIA, INC.
 
 
 
 
13.2.7
CREATIVE BIOLABS
 
 
 
 
13.2.8
SYNBIO TECHNOLOGIES LLC
 
 
 
 
13.2.9
SYSTEM BIOSCIENCES, LLC
 
 
 
 
13.2.10
VECTORBUILDER INC.
 
 
14
APPENDIX
 
 
 
517
 
14.1
DISCUSSION GUIDE
 
 
 
 
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
14.3
CUSTOMIZATION OPTIONS
 
 
 
 
14.4
RELATED REPORTS
 
 
 
 
14.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
 
 
 
 
TABLE 2
GENE TRANSFER TECHNOLOGIES MARKET: RISK ASSESSMENT ANALYSIS
 
 
 
 
TABLE 3
GENE DELIVERY TECHNOLOGY MARKET: KEY PRODUCT PROVIDERS
 
 
 
 
TABLE 4
GENE DELIVERY TECHNOLOGY MARKET: KEY END USERS
 
 
 
 
TABLE 5
GENE DELIVERY TECHNOLOGY MARKET: REGULATORY BODIES
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE TREND OF GENE DELIVERY REAGENTS/CONSUMABLES, BY KEY PLAYERS, 2021–2023
 
 
 
 
TABLE 7
KEY PATENTS IN GENE TRANSFER TECHNOLOGIES MARKET, 2021–2024
 
 
 
 
TABLE 8
IMPORT VOLUME FOR HS CODE 854330, 2019–2023 (UNITS)
 
 
 
 
TABLE 9
EXPORT VOLUME FOR HS CODE 854330, 2019–2023 (UNITS)
 
 
 
 
TABLE 10
GENE TRANSFER TECHNOLOGIES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
 
 
 
 
TABLE 11
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 13
ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 14
REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 15
GENE TRANSFER TECHNOLOGIES MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 16
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
 
 
 
 
TABLE 17
GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 18
GENE DELIVERY REAGENTS, KITS, AND ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 19
NORTH AMERICA: GENE DELIVERY REAGENTS, KITS, AND ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 20
EUROPE: GENE DELIVERY REAGENTS, KITS, AND ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 21
ASIA PACIFIC: GENE DELIVERY REAGENTS, KITS, AND ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 22
LATIN AMERICA: GENE DELIVERY REAGENTS, KITS, AND ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 23
MIDDLE EAST: GENE DELIVERY REAGENTS, KITS, AND ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 24
GCC COUNTRIES: GENE DELIVERY REAGENTS, KITS, AND ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 25
GENE DELIVERY CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 26
NORTH AMERICA: GENE DELIVERY CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 27
EUROPE: GENE DELIVERY CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 28
ASIA PACIFIC: GENE DELIVERY CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 29
LATIN AMERICA: GENE DELIVERY CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 30
MIDDLE EAST: GENE DELIVERY CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 31
GCC COUNTRIES: GENE DELIVERY CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 32
GENE DELIVERY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 33
NORTH AMERICA: GENE DELIVERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 34
EUROPE: GENE DELIVERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 35
ASIA PACIFIC: GENE DELIVERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 36
LATIN AMERICA: GENE DELIVERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 37
MIDDLE EAST: GENE DELIVERY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 38
GCC COUNTRIES: GENE DELIVERY INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 39
OTHER GENE DELIVERY PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 40
OTHER GENE DELIVERY PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 41
EUROPE: OTHER GENE DELIVERY PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 42
ASIA PACIFIC: OTHER GENE DELIVERY PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 43
LATIN AMERICA: OTHER GENE DELIVERY PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 44
MIDDLE EAST: OTHER GENE DELIVERY PRODUCTS MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 45
GCC COUNTRIES: OTHER GENE DELIVERY PRODUCTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 46
GENE TRANSFER TECHNOLOGIES MARKET BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 47
VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 48
VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 49
NORTH AMERICA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 50
EUROPE: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 51
ASIA PACIFIC: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 52
LATIN AMERICA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 53
MIDDLE EAST: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 54
GCC COUNTRIES: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 55
RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 56
RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 57
NORTH AMERICA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 58
EUROPE: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 59
ASIA PACIFIC: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 60
LATIN AMERICA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 61
MIDDLE EAST: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 62
GCC COUNTRIES: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 63
LENTIVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 64
NORTH AMERICA: LENTIVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 65
EUROPE: LENTIVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 66
ASIA PACIFIC: LENTIVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 67
LATIN AMERICA: LENTIVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 68
MIDDLE EAST: LENTIVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 69
GCC COUNTRIES: LENTIVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 70
OTHER RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 71
NORTH AMERICA: OTHER RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 72
EUROPE: OTHER RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 73
ASIA PACIFIC: OTHER RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 74
LATIN AMERICA: OTHER RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 75
MIDDLE EAST: OTHER RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 76
GCC COUNTRIES: OTHER RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 77
ADENOVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 78
NORTH AMERICA: ADENOVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 79
EUROPE: ADENOVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 80
ASIA PACIFIC: ADENOVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 81
LATIN AMERICA: ADENOVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 82
MIDDLE EAST: ADENOVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 83
GCC COUNTRIES: ADENOVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 84
AAV-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 85
NORTH AMERICA: AAV-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 86
EUROPE: AAV-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 87
ASIA PACIFIC: AAV-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 88
LATIN AMERICA: AAV-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 89
MIDDLE EAST: AAV-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 90
GCC COUNTRIES: AAV-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 91
OTHER VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 92
NORTH AMERICA: OTHER VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 93
EUROPE: OTHER VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 94
ASIA PACIFIC: OTHER VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 95
LATIN AMERICA: OTHER VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 96
MIDDLE EAST: OTHER VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 97
GCC COUNTRIES: OTHER VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 98
NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 99
NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 100
NORTH AMERICA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 101
EUROPE: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 102
ASIA PACIFIC: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 103
LATIN AMERICA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 104
MIDDLE EAST: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 105
GCC COUNTRIES: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 106
CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 107
CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 108
NORTH AMERICA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 109
EUROPE: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 110
ASIA PACIFIC: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 111
LATIN AMERICA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 112
MIDDLE EAST: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 113
GCC COUNTRIES: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 114
LIPOSOME-MEDIATED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 115
NORTH AMERICA: LIPOSOME-MEDIATED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 116
EUROPE: LIPOSOME-MEDIATED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 117
ASIA PACIFIC: LIPOSOME-MEDIATED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 118
LATIN AMERICA: LIPOSOME-MEDIATED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 119
MIDDLE EAST: LIPOSOME-MEDIATED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 120
GCC COUNTRIES: LIPOSOME-MEDIATED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 121
CALCIUM PHOSPHATE-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 122
NORTH AMERICA: CALCIUM PHOSPHATE-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 123
EUROPE: CALCIUM PHOSPHATE-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 124
ASIA PACIFIC: CALCIUM PHOSPHATE-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 125
LATIN AMERICA: CALCIUM PHOSPHATE-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 126
MIDDLE EAST: CALCIUM PHOSPHATE-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 127
GCC COUNTRIES: CALCIUM PHOSPHATE-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 128
DEAE-DEXTRAN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 129
NORTH AMERICA: DEAE-DEXTRAN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 130
EUROPE: DEAE-DEXTRAN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 131
ASIA PACIFIC: DEAE-DEXTRAN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 132
LATIN AMERICA: DEAE-DEXTRAN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 133
MIDDLE EAST: DEAE-DEXTRAN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 134
GCC COUNTRIES: DEAE-DEXTRAN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 135
CATIONIC POLYMER-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 136
NORTH AMERICA: CATIONIC POLYMER-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 137
EUROPE: CATIONIC POLYMER-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 138
ASIA PACIFIC: CATIONIC POLYMER-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 139
LATIN AMERICA: CATIONIC POLYMER-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 140
MIDDLE EAST: CATIONIC POLYMER-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 141
GCC COUNTRIES: CATIONIC POLYMER-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 142
OTHER CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 143
NORTH AMERICA: OTHER CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 144
EUROPE: OTHER CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 145
ASIA PACIFIC: OTHER CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 146
LATIN AMERICA: OTHER CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 147
MIDDLE EAST: OTHER CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 148
GCC COUNTRIES: OTHER CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 149
PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 150
PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 151
NORTH AMERICA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 152
EUROPE: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 153
ASIA PACIFIC: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 154
LATIN AMERICA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 155
MIDDLE EAST: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 156
GCC COUNTRIES: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 157
ELECTROPORATION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 158
NORTH AMERICA: ELECTROPORATION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 159
EUROPE: ELECTROPORATION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 160
ASIA PACIFIC: ELECTROPORATION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 161
LATIN AMERICA: ELECTROPORATION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 162
MIDDLE EAST: ELECTROPORATION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 163
GCC COUNTRIES: ELECTROPORATION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 164
MICROINJECTION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 165
NORTH AMERICA: MICROINJECTION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 166
EUROPE: MICROINJECTION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 167
ASIA PACIFIC: MICROINJECTION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 168
LATIN AMERICA: MICROINJECTION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 169
MIDDLE EAST: MICROINJECTION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 170
GCC COUNTRIES: MICROINJECTION-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 171
GENE GUN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 172
NORTH AMERICA: GENE GUN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 173
EUROPE: GENE GUN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 174
ASIA PACIFIC: GENE GUN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 175
LATIN AMERICA: GENE GUN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 176
MIDDLE EAST: GENE GUN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 177
GCC COUNTRIES: GENE GUN-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 178
OTHER PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 179
NORTH AMERICA: OTHER PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 180
EUROPE: OTHER PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 181
ASIA PACIFIC: OTHER PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 182
LATIN AMERICA: OTHER PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 183
MIDDLE EAST: OTHER PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 184
GCC COUNTRIES: OTHER PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 185
GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 186
IN VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 187
NORTH AMERICA: IN VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 188
EUROPE: IN VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 189
ASIA PACIFIC: IN VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 190
LATIN AMERICA: IN VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 191
MIDDLE EAST: IN VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 192
GCC COUNTRIES: IN VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 193
EX VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 194
NORTH AMERICA: EX VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 195
EUROPE: EX VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 196
ASIA PACIFIC: EX VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 197
LATIN AMERICA: EX VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 198
MIDDLE EAST: EX VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 199
GCC COUNTRIES: EX VIVO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 200
IN VITRO GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 201
NORTH AMERICA: IN VITRO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 202
EUROPE: IN VITRO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 203
ASIA PACIFIC: IN VITRO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 204
LATIN AMERICA: IN VITRO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 205
MIDDLE EAST: IN VITRO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 206
GCC COUNTRIES: IN VITRO GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 207
GENE TRANSFER TECHNOLOGIES MARKET BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 208
GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 209
GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 210
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 211
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 212
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 213
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 214
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 215
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 216
GENE TRANSFER TECHNOLOGIES MARKET FOR GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 217
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 218
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 219
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 220
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 221
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 222
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 223
GENE TRANSFER TECHNOLOGIES MARKET FOR CELL THERAPY, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 224
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR CELL THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 225
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR CELL THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 226
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR CELL THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 227
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR CELL THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 228
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR CELL THERAPY, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 229
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR CELL THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 230
GENE TRANSFER TECHNOLOGIES MARKET FOR VACCINES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 231
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 232
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 233
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 234
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 235
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR VACCINES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 236
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR VACCINES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 237
GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 238
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 239
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 240
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 241
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 242
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 243
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 244
GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 245
GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 246
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 247
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 248
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 249
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 250
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 251
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 252
GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 253
GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 254
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 255
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 256
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 257
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 258
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 259
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 260
GENE TRANSFER TECHNOLOGIES MARKET FOR CANCER, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 261
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 262
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 263
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 264
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 265
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR CANCER, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 266
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 267
GENE TRANSFER TECHNOLOGIES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 268
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 269
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 270
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 271
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 272
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR INFECTIOUS DISEASES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 273
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 274
GENE TRANSFER TECHNOLOGIES MARKET FOR GENETIC & NEUROLOGICAL DISORDERS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 275
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR GENETIC & NEUROLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 276
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR GENETIC & NEUROLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 277
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR GENETIC & NEUROLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 278
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR GENETIC & NEUROLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 279
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR GENETIC & NEUROLOGICAL DISORDERS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 280
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR GENETIC & NEUROLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 281
GENE TRANSFER TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 282
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 283
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 284
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 285
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 286
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 287
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 288
GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER DISEASES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 289
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 290
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 291
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 292
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 293
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER DISEASES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 294
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER DISEASES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 295
GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 296
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 297
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 298
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 299
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 300
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 301
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 302
GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 303
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 304
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 305
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 306
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 307
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 308
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 309
GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 310
GENE TRANSFER TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 311
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 312
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 313
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 314
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 315
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 316
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 317
GENE TRANSFER TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 318
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 319
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 320
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 321
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 322
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 323
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 324
GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 325
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 326
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 327
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 328
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 329
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 330
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 331
GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 332
NORTH AMERICA: KEY MACROINDICATORS
 
 
 
 
TABLE 333
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 334
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 335
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 336
NORTH AMERICA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 337
NORTH AMERICA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 338
NORTH AMERICA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 339
NORTH AMERICA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 340
NORTH AMERICA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 341
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 342
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 343
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 344
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 345
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 346
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 347
US: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 348
US: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 349
US: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 350
US: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 351
US: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 352
US: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 353
US: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 354
US: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 355
US: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 356
US: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 357
US: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 358
US: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 359
US: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 360
CANADA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 361
CANADA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 362
CANADA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 363
CANADA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 364
CANADA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 365
CANADA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 366
CANADA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 367
CANADA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 368
CANADA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 369
CANADA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 370
CANADA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 371
CANADA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 372
CANADA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 373
EUROPE: KEY MACROINDICATORS
 
 
 
 
TABLE 374
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 375
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 376
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 377
EUROPE: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 378
EUROPE: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 379
EUROPE: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 380
EUROPE: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 381
EUROPE: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 382
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 383
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 384
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 385
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 386
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 387
EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 388
GERMANY: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 389
GERMANY: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 390
GERMANY: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 391
GERMANY: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 392
GERMANY: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 393
GERMANY: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 394
GERMANY: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 395
GERMANY: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 396
GERMANY: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 397
GERMANY: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 398
GERMANY: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 399
GERMANY: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 400
GERMANY: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 401
UK: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 402
UK: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 403
UK: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 404
UK: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 405
UK: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 406
UK: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 407
UK: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 408
UK: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 409
UK: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 410
UK: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 411
UK: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 412
UK: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 413
UK: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 414
FRANCE: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 415
FRANCE: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 416
FRANCE: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 417
FRANCE: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 418
FRANCE: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 419
FRANCE: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 420
FRANCE: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 421
FRANCE: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 422
FRANCE: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 423
FRANCE: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 424
FRANCE: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 425
FRANCE: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 426
FRANCE: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 427
ITALY: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 428
ITALY: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 429
ITALY: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 430
ITALY: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 431
ITALY: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 432
ITALY: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 433
ITALY: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 434
ITALY: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 435
ITALY: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 436
ITALY: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 437
ITALY: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 438
ITALY: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 439
ITALY: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 440
SPAIN: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 441
SPAIN: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 442
SPAIN: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 443
SPAIN: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 444
SPAIN: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 445
SPAIN: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 446
SPAIN: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 447
SPAIN: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 448
SPAIN: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 449
SPAIN: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 450
SPAIN: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 451
SPAIN: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 452
SPAIN: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 453
REST OF EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 454
REST OF EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 455
REST OF EUROPE: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 456
REST OF EUROPE: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 457
REST OF EUROPE: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 458
REST OF EUROPE: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 459
REST OF EUROPE: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 460
REST OF EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 461
REST OF EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 462
REST OF EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 463
REST OF EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 464
REST OF EUROPE: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 465
REST OF EUROPE: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 466
ASIA PACIFIC: KEY MACROINDICATORS
 
 
 
 
TABLE 467
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 468
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 469
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 470
ASIA PACIFIC: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 471
ASIA PACIFIC: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 472
ASIA PACIFIC: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 473
ASIA PACIFIC: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 474
ASIA PACIFIC: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 475
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 476
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 477
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 478
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 479
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 480
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 481
CHINA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 482
CHINA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 483
CHINA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 484
CHINA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 485
CHINA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 486
CHINA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 487
CHINA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 488
CHINA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 489
CHINA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 490
CHINA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 491
CHINA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 492
CHINA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 493
CHINA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 494
JAPAN: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 495
JAPAN: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 496
JAPAN: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 497
JAPAN: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 498
JAPAN: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 499
JAPAN: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 500
JAPAN: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 501
JAPAN: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 502
JAPAN: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 503
JAPAN: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 504
JAPAN: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 505
JAPAN: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 506
JAPAN: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 507
INDIA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 508
INDIA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 509
INDIA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 510
INDIA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 511
INDIA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 512
INDIA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 513
INDIA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 514
INDIA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 515
INDIA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 516
INDIA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 517
INDIA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 518
INDIA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 519
INDIA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 520
SOUTH KOREA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 521
SOUTH KOREA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 522
SOUTH KOREA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 523
SOUTH KOREA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 524
SOUTH KOREA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 525
SOUTH KOREA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 526
SOUTH KOREA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 527
SOUTH KOREA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 528
SOUTH KOREA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 529
SOUTH KOREA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 530
SOUTH KOREA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 531
SOUTH KOREA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 532
SOUTH KOREA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 533
AUSTRALIA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 534
AUSTRALIA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 535
AUSTRALIA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 536
AUSTRALIA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 537
AUSTRALIA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 538
AUSTRALIA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 539
AUSTRALIA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 540
AUSTRALIA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 541
AUSTRALIA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 542
AUSTRALIA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 543
AUSTRALIA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 544
AUSTRALIA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 545
AUSTRALIA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 546
REST OF ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 547
REST OF ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 548
REST OF ASIA PACIFIC: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 549
REST OF ASIA PACIFIC: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 550
REST OF ASIA PACIFIC: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 551
REST OF ASIA PACIFIC: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 552
REST OF ASIA PACIFIC: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 553
REST OF ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 554
REST OF ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 555
REST OF ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 556
REST OF ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 557
REST OF ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 558
REST OF ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 559
LATIN AMERICA: KEY MACROINDICATORS
 
 
 
 
TABLE 560
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 561
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 562
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 563
LATIN AMERICA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 564
LATIN AMERICA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 565
LATIN AMERICA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 566
LATIN AMERICA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 567
LATIN AMERICA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 568
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 569
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 570
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 571
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 572
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 573
LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 574
BRAZIL: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 575
BRAZIL: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 576
BRAZIL: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 577
BRAZIL: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 578
BRAZIL: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 579
BRAZIL: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 580
BRAZIL: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 581
BRAZIL: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 582
BRAZIL: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 583
BRAZIL: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 584
BRAZIL: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 585
BRAZIL: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 586
BRAZIL: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 587
MEXICO: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 588
MEXICO: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 589
MEXICO: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 590
MEXICO: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 591
MEXICO: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 592
MEXICO: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 593
MEXICO: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 594
MEXICO: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 595
MEXICO: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 596
MEXICO: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 597
MEXICO: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 598
MEXICO: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 599
MEXICO: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 600
REST OF LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 601
REST OF LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 602
REST OF LATIN AMERICA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 603
REST OF LATIN AMERICA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 604
REST OF LATIN AMERICA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 605
REST OF LATIN AMERICA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 606
REST OF LATIN AMERICA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 607
REST OF LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 608
REST OF LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 609
REST OF LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 610
REST OF LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 611
REST OF LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 612
REST OF LATIN AMERICA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 613
MIDDLE EAST: KEY MACROINDICATORS
 
 
 
 
TABLE 614
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY REGION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 615
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 616
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 617
MIDDLE EAST: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 618
MIDDLE EAST: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 619
MIDDLE EAST: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 620
MIDDLE EAST: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 621
MIDDLE EAST: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 622
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 623
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 624
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 625
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 626
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 627
MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 628
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 629
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 630
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 631
GCC COUNTRIES: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 632
GCC COUNTRIES: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 633
GCC COUNTRIES: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 634
GCC COUNTRIES: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 635
GCC COUNTRIES: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 636
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 637
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 638
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 639
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 640
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 641
GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 642
SAUDI ARABIA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 643
SAUDI ARABIA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 644
SAUDI ARABIA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 645
SAUDI ARABIA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 646
SAUDI ARABIA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 647
SAUDI ARABIA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 648
SAUDI ARABIA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 649
SAUDI ARABIA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 650
SAUDI ARABIA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 651
SAUDI ARABIA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 652
SAUDI ARABIA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 653
SAUDI ARABIA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 654
SAUDI ARABIA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 655
UAE: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 656
UAE: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 657
UAE: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 658
UAE: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 659
UAE: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 660
UAE: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 661
UAE: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 662
UAE: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 663
UAE: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 664
UAE: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 665
UAE: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 666
UAE: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 667
UAE: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 668
REST OF GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 669
REST OF GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 670
REST OF GCC COUNTRIES: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 671
REST OF GCC COUNTRIES: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 672
REST OF GCC COUNTRIES: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 673
REST OF GCC COUNTRIES: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 674
REST OF GCC COUNTRIES: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 675
REST OF GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 676
REST OF GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 677
REST OF GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 678
REST OF GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 679
REST OF GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 680
REST OF GCC COUNTRIES: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 681
REST OF MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 682
REST OF MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 683
REST OF MIDDLE EAST: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 684
REST OF MIDDLE EAST: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 685
REST OF MIDDLE EAST: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 686
REST OF MIDDLE EAST: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 687
REST OF MIDDLE EAST: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 688
REST OF MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 689
REST OF MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 690
REST OF MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 691
REST OF MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 692
REST OF MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 693
REST OF MIDDLE EAST: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 694
AFRICA: KEY MACROINDICATORS
 
 
 
 
TABLE 695
AFRICA: GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 696
AFRICA: GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 697
AFRICA: VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 698
AFRICA: RETROVIRUS-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 699
AFRICA: NON-VIRAL VECTOR-BASED GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 700
AFRICA: CHEMICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 701
AFRICA: PHYSICAL GENE TRANSFER TECHNOLOGIES MARKET, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 702
AFRICA: GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 703
AFRICA: GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 704
AFRICA: GENE TRANSFER TECHNOLOGIES MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 705
AFRICA: GENE TRANSFER TECHNOLOGIES MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 706
AFRICA: GENE TRANSFER TECHNOLOGIES MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 707
AFRICA: GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2022–2029 (USD MILLION)
 
 
 
 
TABLE 708
OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
 
 
 
 
TABLE 709
GENE TRANSFER TECHNOLOGIES MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 710
GENE TRANSFER TECHNOLOGIES MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 711
GENE TRANSFER TECHNOLOGIES MARKET: PRODUCT FOOTPRINT
 
 
 
 
TABLE 712
GENE TRANSFER TECHNOLOGIES MARKET: METHOD FOOTPRINT
 
 
 
 
TABLE 713
GENE TRANSFER TECHNOLOGIES MARKET: APPLICATION FOOTPRINT
 
 
 
 
TABLE 714
GENE TRANSFER TECHNOLOGIES MARKET: END-USER FOOTPRINT
 
 
 
 
TABLE 715
GENE TRANSFER TECHNOLOGIES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 716
GENE TRANSFER TECHNOLOGIES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
TABLE 717
GENE TRANSFER TECHNOLOGIES MARKET: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 718
GENE TRANSFER TECHNOLOGIES MARKET: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 719
GENE TRANSFER TECHNOLOGIES MARKET: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 720
THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
 
 
 
 
TABLE 721
THERMO FISHER SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 722
THERMO FISHER SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 723
THERMO FISHER SCIENTIFIC: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 724
DANAHER CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 725
DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 726
DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 727
DANAHER CORPORATION: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 728
DANAHER CORPORATION: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 729
MERCK: COMPANY OVERVIEW
 
 
 
 
TABLE 730
MERCK: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 731
MERCK: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 732
MERCK: EXPANSIONS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 733
BIO-RAD LABORATORIES: COMPANY OVERVIEW
 
 
 
 
TABLE 734
BIO-RAD LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 735
AGILENT TECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
TABLE 736
AGILENT TECHNOLOGIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 737
AGILENT TECHNOLOGIES: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 738
REVVITY: COMPANY OVERVIEW
 
 
 
 
TABLE 739
REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 740
REVVITY: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 741
REVVITY: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 742
QIAGEN: COMPANY OVERVIEW
 
 
 
 
TABLE 743
QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 744
GENSCRIPT: COMPANY OVERVIEW
 
 
 
 
TABLE 745
GENSCRIPT: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 746
GENSCRIPT: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 747
TAKARA BIO: COMPANY OVERVIEW
 
 
 
 
TABLE 748
TAKARA BIO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 749
TAKARA BIO: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 750
TAKARA BIO: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 751
PROMEGA CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 752
PROMEGA CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 753
BIO-TECHNE: COMPANY OVERVIEW
 
 
 
 
TABLE 754
BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 755
BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 756
LONZA: COMPANY OVERVIEW
 
 
 
 
TABLE 757
LONZA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 758
LONZA: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 759
LONZA: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 760
OXFORD BIOMEDICA: COMPANY OVERVIEW
 
 
 
 
TABLE 761
OXFORD BIOMEDICA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 762
OXFORD BIOMEDICA: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 763
OXFORD BIOMEDICA: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 764
OXFORD BIOMEDICA: OTHER DEVELOPMENTS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 765
SARTORIUS: COMPANY OVERVIEW
 
 
 
 
TABLE 766
SARTORIUS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 767
SARTORIUS: PRODUCT LAUNCHES, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 768
SARTORIUS: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
TABLE 769
MAXCYTE: COMPANY OVERVIEW
 
 
 
 
TABLE 770
MAXCYTE: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 771
MAXCYTE: DEALS, JANUARY 2021–SEPTEMBER 2024
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
GENE TRANSFER TECHNOLOGIES MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
FIGURE 2
RESEARCH DESIGN
 
 
 
 
FIGURE 3
BREAKDOWN OF PRIMARIES: GENE TRANSFER TECHNOLOGIES MARKET
 
 
 
 
FIGURE 4
GENE TRANSFER TECHNOLOGIES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
 
 
 
 
FIGURE 5
GLOBAL MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
 
 
 
 
FIGURE 6
ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC: REVENUE SHARE ANALYSIS (2023)
 
 
 
 
FIGURE 7
MARKET SIZE VALIDATION FROM PRIMARY SOURCES
 
 
 
 
FIGURE 8
MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
 
 
 
 
FIGURE 9
GENE TRANSFER TECHNOLOGIES MARKET: CAGR PROJECTIONS
 
 
 
 
FIGURE 10
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 11
GENE TRANSFER TECHNOLOGIES MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 12
GENE TRANSFER TECHNOLOGIES MARKET, BY MODE, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 13
GENE TRANSFER TECHNOLOGIES MARKET, BY METHOD, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 14
GENE TRANSFER TECHNOLOGIES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 15
GENE TRANSFER TECHNOLOGIES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
 
 
 
 
FIGURE 16
GEOGRAPHICAL SNAPSHOT OF GENE TRANSFER TECHNOLOGIES MARKET
 
 
 
 
FIGURE 17
INCREASED INVESTMENTS IN GENE THERAPY RESEARCH TO DRIVE MARKET
 
 
 
 
FIGURE 18
RESEARCH APPLICATIONS HELD LARGEST MARKET SHARE IN NORTH AMERICA (2023)
 
 
 
 
FIGURE 19
VIRAL VECTORS SEGMENT TO DOMINATE MARKET TILL 2029
 
 
 
 
FIGURE 20
CHINA TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029
 
 
 
 
FIGURE 21
GENE TRANSFER TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 22
US: PREVALENCE OF CANCER, 2017–2023
 
 
 
 
FIGURE 23
GENE TRANSFER TECHNOLOGIES MARKET: ECOSYSTEM
 
 
 
 
FIGURE 24
AVERAGE SELLING PRICE TREND OF GENE DELIVERY INSTRUMENTS, 2023 (USD THOUSAND)
 
 
 
 
FIGURE 25
GENE TRANSFER TECHNOLOGIES MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 26
GENE TRANSFER TECHNOLOGIES MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
FIGURE 27
GENE TRANSFER TECHNOLOGIES MARKET: OVERVIEW OF PATENTING ACTIVITY
 
 
 
 
FIGURE 28
GENE TRANSFER TECHNOLOGIES MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 29
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
 
 
 
 
FIGURE 30
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
FIGURE 31
REVENUE SHIFT IN GENE TRANSFER TECHNOLOGIES MARKET
 
 
 
 
FIGURE 32
GENE TRANSFER TECHNOLOGIES MARKET: IMPACT OF AI
 
 
 
 
FIGURE 33
NORTH AMERICA: GENE TRANSFER TECHNOLOGIES MARKET SNAPSHOT
 
 
 
 
FIGURE 34
ASIA PACIFIC: GENE TRANSFER TECHNOLOGIES MARKET SNAPSHOT
 
 
 
 
FIGURE 35
REVENUE ANALYSIS OF KEY PLAYERS IN GENE TRANSFER TECHNOLOGIES MARKET, 2021–2023
 
 
 
 
FIGURE 36
MARKET SHARE ANALYSIS OF KEY PLAYERS IN GENE TRANSFER TECHNOLOGIES MARKET, 2023
 
 
 
 
FIGURE 37
GENE TRANSFER TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
 
 
 
 
FIGURE 38
GENE TRANSFER TECHNOLOGIES MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 39
GENE TRANSFER TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
 
 
 
 
FIGURE 40
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 41
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 42
GENE TRANSFER TECHNOLOGIES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 43
THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
 
 
 
 
FIGURE 44
DANAHER CORPORATION: COMPANY SNAPSHOT
 
 
 
 
FIGURE 45
MERCK: COMPANY SNAPSHOT
 
 
 
 
FIGURE 46
BIO-RAD LABORATORIES: COMPANY SNAPSHOT
 
 
 
 
FIGURE 47
AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
 
 
 
 
FIGURE 48
REVVITY: COMPANY SNAPSHOT
 
 
 
 
FIGURE 49
QIAGEN: COMPANY SNAPSHOT
 
 
 
 
FIGURE 50
GENSCRIPT: COMPANY SNAPSHOT
 
 
 
 
FIGURE 51
TAKARA BIO: COMPANY SNAPSHOT
 
 
 
 
FIGURE 52
BIO-TECHNE: COMPANY SNAPSHOT
 
 
 
 
FIGURE 53
LONZA: COMPANY SNAPSHOT
 
 
 
 
FIGURE 54
OXFORD BIOMEDICA: COMPANY SNAPSHOT
 
 
 
 
FIGURE 55
SARTORIUS: COMPANY SNAPSHOT
 
 
 
 
FIGURE 56
MAXCYTE: COMPANY SNAPSHOT
 
 
 
 

 

Methodology

The research study involved the wide use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global gene transfer technologies market. Extensive interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size estimated through secondary research (top down and bottom-up) followed by data triangulation with inputs from industry experts to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the technical, market-oriented, and commercial study of the gene transfer technologies market. The secondary sources used for this study include World Health Organization (WHO), the National Institutes of Health (NIH), the United States Food and Drug Administration (US FDA), European Medicines Agency (EMA), Alliance for Regenerative Medicine (ARM), International Society for Cell & Gene Therapy (ISCT), American Society of Gene & Cell Therapy (ASGCT), Regenerative Medicine Manufacturing Society (RMMS), Biotechnology Innovation Organization (BIO), European Society of Gene and Cell Therapy (ESGCT), International Society for Stem Cell Research (ISSCR), Personalized Medicine Coalition & Personalized Medicines Bulletin, ScienceDirect, Eurostat, research journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These secondary sources were also used to obtain major information about key market players, and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analysed to arrive at the market size of the global gene transfer technologies market, which was further validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global gene transfer technologies market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical industry, nutraceutical industry, cosmetic industry from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. The primary interviews were conducted across five major regions, including the North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Gene Transfer Technologies Market

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the gene transfer technologies market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

 

Gene Transfer Technologies Market

Data Triangulation

After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Gene transfer is a process where genetic material, such as DNA or RNA, can be transferred to target cells through viral and non-viral vectors. Viral methods used genetically engineered viruses for genetic material delivery, usually resulting in highly efficient delivery, while the non-viral methods depend on lipids, polymers or nanoparticles to achieve the objective. Both of these have become essential in the pursuit of new treatments and as a driving force for future development in genetic studies and biopharmaceutical production.

Stakeholders

  • Gene Transfer Technologies Manufacturers
  • Academic & Research Institutes
  • Biotechnology Companies
  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Market Research & Consulting Firms
  • Venture Capitalists & Investors
  • Government Associations

Report Objectives

  • To define, describe, analyze, and forecast the gene transfer technologies market by product, mode, method, application, end user, and region
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges).
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gene transfer technologies market.
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to five main regions: North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa
  • To profile the key players and analyze their market shares and core competencies?
  • To track and analyze competitive developments, such as acquisitions, product launches, expansions, agreements, partnerships, and collaborations.
  • To benchmark players within the market using the proprietary "Company Evaluation Matrix" framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategies.

Key Questions Addressed by the Report

Who are the key players in the gene transfer technologies market?

Key players in the gene transfer technologies market include Lonza (Switzerland), ACG (India), Qualicaps (Roquette Freres) (US), Suheung Co. Ltd. (South Korea), Shanxi Guangsheng Capsule Limited (China), and CapsCanada (Lyfe Group) (US).

Which product segment dominates the gene transfer technologies market?

The market, by product, is segmented as instruments, consumables, reagents, kits & assays and other products. The reagents, kits & assays segment dominated the market in 2023.

Which mode segment dominates the gene transfer technologies market?

The market, by type, is segmented as viral vector and non-viral vector. The viral vector segment dominated the market in 2023.

Which method segment dominates the gene transfer technologies market?

The market, by method, is segmented as ex vivo, in vivo and in vitro. The in vivo segment dominated the market in 2023

Which application segment dominates the gene transfer technologies market?

The market, by application, is segmented as research, therapeutic and other application. The therapeutic application segment dominated the market in 2023.

Which end-user segment of the gene transfer technologies market is expected to register the highest growth?

The academic & research institutes segment is anticipated to register the highest CAGR during the forecast period.

What is the market size for the gene transfer technologies market?

The global gene transfer technologies market is anticipated to reach USD 5.93 billion in 2029 from USD 3.73 billion in 2024, with a significant CAGR of 9.7%.

TABLE OF CONTENTS

METHODOLOGY

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Gene Transfer Technologies Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request
Forbes

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Gene Transfer Technologies Market

DMCA.com Protection Status